文献速递主动脉疾病

远端锥形限制性覆膜支架在累及0区主动脉夹层腔内治疗中的临床结果

Clinical Outcomes of Distal Tapered Restrictive Covered Stent Applied in Endovascular Treatment of Aortic Dissection Involving Zone 0.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2021-01-07

本研究回顾性分析43例累及0区的急性主动脉夹层患者,均接受原位激光开窗胸主动脉腔内修复术并应用远端锥形限制性覆膜支架。

要点

  • 远端锥形限制性覆膜支架用于0区主动脉夹层腔内治疗技术成功率高,30天死亡率低。
  • 随访期间支架覆盖段假腔完全血栓化,主动脉重塑良好,无远端支架诱导的新发破口。
  • 脊髓缺血发生率低,经保守治疗均恢复,无永久性截瘫。

核心结论

  • 远端锥形限制性覆膜支架用于累及0区主动脉夹层的腔内治疗可行且有效,主动脉重塑满意,远端支架诱导的新发破口和脊髓缺血风险低。
  • 良好结果部分归因于患者选择,所有患者破口均不靠近冠状动脉,修复时冠状动脉、心包和主动脉瓣均未受累。

研究设计与样本

  • 回顾性分析2015年1月至2019年2月43例累及0区的急性主动脉夹层患者,均接受原位激光开窗胸主动脉腔内修复术并应用远端锥形限制性覆膜支架。
  • 远端锥形限制性覆膜支架的指征为主支架移植物远端尺寸不合适。

主要发现

  • 所有患者技术成功,30天术后死亡率为0%。
  • 所有患者支架覆盖段假腔完全血栓化。
  • 基线至12个月,真腔体积显著增加(p < .001),平均变化87.0% ± 34.3%;假腔体积显著减小(p < .001),平均变化-71.0% ± 13.5%。
  • 随访期间(平均28.7个月,范围12-63个月)未观察到远端支架诱导的新发破口。
  • 远端锥形限制性覆膜支架末端与腹腔干平均距离57.5 mm;2例(4.7%)发生脊髓缺血,保守治疗后恢复,无永久性截瘫。

临床怎么用

  • 对于累及0区且主支架远端尺寸不合适的主动脉夹层患者,可考虑应用远端锥形限制性覆膜支架辅助腔内治疗。
  • 术后需关注主动脉重塑及脊髓缺血等并发症,本组脊髓缺血经保守治疗可恢复。

局限性

  • 本研究为回顾性分析,样本量43例,随访时间有限。
  • 良好结果部分归因于患者选择,所有患者破口均不靠近冠状动脉,修复时冠状动脉、心包和主动脉瓣均未受累。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The safety and efficacy of a distal tapered restrictive covered stent (RCS) applied in the endovascular treatment of aortic dissection involving Zone 0 was evaluated. METHODS: This study retrospectively analysed 43 patients with acute aortic dissection involving Zone 0 who received in situ laser fenestrated thoracic endovascular aortic repair with distal tapered RCS from January 2015 to February 2019. The indication for the distal tapered RCS procedure was an inappropriate distal size of the main stent graft. Technical success, aortic remodelling, and clinical outcomes were evaluated. RESULTS: Technical success was achieved in all patients. The 30 day post-operative mortality rate was 0%. All patients had complete false lumen thrombosis in the stent coverage segment. True lumen volume increased significantly (p < .001) with an average change of 87.0% ± 34.3%, while false lumen volume decreased significantly (p < .001) with an average change of -71.0% ± 13.5% between baseline and 12 months. During the follow up period (mean 28.7 months, range 12-63 months), no distal stent graft induced new entry (SINE) was observed. The average distance between the distal end of the RCS and the coeliac trunk was 57.5 mm. Two (4.7%) patients had spinal cord ischaemia (SCI) and recovered without permanent paraplegia after undergoing conservative treatment. CONCLUSION: The distal tapered RCS applied in the endovascular treatment of aortic dissection involving Zone 0 is considered to be a feasible and effective approach along with satisfactory aortic remodelling, a low risk of SINE, and SCI. The favourable results are partly explained by selection. No patients had an entry tear near the coronary artery, nor were the coronary arteries, pericardium, or aortic valve involved at the time of repair.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Li F, Wu X, Zhang X, et al. Clinical Outcomes of Distal Tapered Restrictive Covered Stent Applied in Endovascular Treatment of Aortic Dissection Involving Zone 0. Eur J Vasc Endovasc Surg. 2021. PMID: 33422438. doi:10.1016/j.ejvs.2020.11.037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。